Luminous Mind, Inc. seeks strategic partnerships with leading nutraceutical, supplement, pharmaceutical, and venture groups to bring breakthrough products to market, potentially opening a billion-dollar-plus opportunity. BOSTON, Oct. 6, 2026 /PRNewswire/ -- Luminous Mind, Inc. (LMI), a...
Agreement expands counter-UAS portfolio with patented physical-capture and communications-isolation technology for defense, homeland security, and critical-infrastructure protection applications. HOBOKEN, N.J., Oct. 6, 2026 /PRNewswire/ -- Rocket One Inc. (Nasdaq: RKTO) ("Rocket One" or...
CollPlant Advances its Photonic Computing Strategy Through LightSolver's Growing IP Portfolio REHOVOT, Israel, Oct. 6, 2026 /PRNewswire/ -- CollPlant Biotechnologies Ltd. (Nasdaq: CLGN) today announced that its subsidiary, LightSolver, has filed a provisional patent application with the U....
ABD merkezli çip üreticisi Qualcomm ile Çinli teknoloji devi Huawei, 5G ve yapay zekayı kapsayan çok yıllı dev bir patent lisanslama anlaşmasına imza attı. Karşılıklı lisanslamaları içeren iş birliği teknoloji dünyasında geniş yankı uyandırdı.
Seimas balsuodamas dėl Mokesčių už pramoninės nuosavybės objektų registravimą įstatymo pakeitimų taip pat padidino kai kuriuos mokesčius už patentus bei įvedė lengvatas.
QIKcap® System QIKcap is HAI Solutions' ultraviolet platform for needle-free IV connectors, built to support more consistent connector care in the hospital. CARLSBAD, Calif., Oct. 5, 2026 /PRNewswire/ -- Issued Patent Advances an AI-Enabled Platform for IV Connector Care HAI Solutions, a...
An anonymous reader quotes a report from Quartz: Huawei and Qualcomm on Monday announced a multi-year, broad patent license agreement covering 5G, artificial intelligence, compute, and networking technologies, along with Qualcomm's purchase of certain Huawei U.S. patents in those same fields. The…
On this episode of Stock Movers: - PTC (PTC) shares are rallying as Schneider Electric agreed to buy PTC for about $22.6 billion in an all-cash deal to tap into the artificial-intelligence boom. - Qualcomm (QCOM) shares are higher as the company agreed to license patents underpinning Huawei…
Patent discloses uses beyond ADCs, including autologous or allogeneic adoptive cellular immunotherapies like CAR-T, Tregs or TIL cell therapies TAMPA, Fla., Oct. 5, 2026 /PRNewswire/ -- TuHURA Biosciences, Inc. (NASDAQ:HURA) ("TuHURA" or the "Company"), a Phase 3 immuno-oncology company...
A new patent application covers Polyrizon’s proprietary mucoadhesive platform and its potential applications in nasal drug delivery.
